Clintrex: About
Russell "Rusty" Katz - Senior Regulatory Advisor

Russell Katz

Dr. Katz joined CLINTREX® in December 2014 as Senior Regulatory Advisor. He attended medical school and trained in Neurology at the Albert Einstein College of Medicine in New York City. He joined the Food and Drug Administration (FDA) in March 1983 as a medical officer in the Division of Neuropharmacological Drug Products (DNDP). Shortly after starting at the FDA, Dr. Katz was named as the Deputy Director of the Division. In November 1999 he was appointed Director of the Division (now known as the Division of Neurological Products) and maintained this position until his retirement in June, 2013.

Dr. Katz has focused his academic interest on scientific and regulatory issues related to drug development. He has published numerous chapters and articles pertaining to all aspect of the development of drugs and biologic products for the treatment of a wide array of neurologic diseases, and has lectured extensively on these topics. He is the recipient of numerous awards and honors including the Ronald and Nancy Reagan Research Award from the Alzheimer's Association, the Lifetime Achievement Award for Alzheimer's Disease Therapeutic Research presented by the Sixth Congress of Clinical Trials on Alzheimer's Disease, the Extraordinary Contributions Award from the American Epilepsy Society; and the FDA Distinguished Career Service Award. Dr. Katz is widely recognized as one of the leading authorities in clinical trial issues and regulatory affairs related to neurological drug development.